HappeningToo

HappeningToo topic

Metformin Hydrochloride Extended-release Tablets reports

Browse community reports connected to Metformin Hydrochloride Extended-release Tablets. These reports can show that other people are describing similar experiences, but they do not prove that Metformin Hydrochloride Extended-release Tablets caused a symptom or reaction.

⚕️ Medicine safety note

Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.

39 problems

Abdominal Discomfort while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and abdominal discomfort appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Distension while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and abdominal distension appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain Upper while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and abdominal pain upper appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and abdominal pain appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Acid reflux while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and acid reflux appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Alopecia while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and alopecia appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Anxiety while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and anxiety appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Back Pain while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and back pain appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Constipation while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and constipation appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Cough while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and cough appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Decreased Appetite while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and decreased appetite appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dehydration while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and dehydration appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Diarrhea while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and diarrhea appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dizziness while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and dizziness appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dyspepsia while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and dyspepsia appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Excessive sweating while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and excessive sweating appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Fatigue while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and fatigue appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Feeling Abnormal while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and feeling abnormal appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Headache while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and headache appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hives while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and hives appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hypotension while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and hypotension appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Insomnia while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and insomnia appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Itching while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and itching appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Malaise while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and malaise appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscle Spasms while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and muscle spasms appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscular Weakness while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and muscular weakness appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Myalgia while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and myalgia appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Nausea while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and nausea appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Pain while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and pain appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Peripheral swelling while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and peripheral swelling appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Rash while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and rash appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Shortness of breath while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and shortness of breath appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Skin redness while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and skin redness appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Sleepiness while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and sleepiness appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Tingling or pins and needles while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and tingling or pins and needles appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vomiting while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and vomiting appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weakness while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and weakness appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Decreased while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and weight decreased appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Increased while using Metformin Hydrochloride Extended-release Tablets

FDA FAERS contains adverse-event reports in which Metformin Hydrochloride Extended-release Tablets and weight increased appear together. This does not establish that Metformin Hydrochloride Extended-release Tablets caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →